CA
NZ
UK
AU
IND
US
A group of related reporting persons led by John C. Goff filed Amendment No. 7 to their Schedule 13D on November 6, 2026, disclosing that their beneficial ownership in GameSquare Holdings, Inc. fell below 5% solely due to dilution from additional Common Stock issued …
United Fire Group, Inc. filed a Form S-8 registration statement with the U.S. Securities and Exchange Commission on November 6, 2026, to register 415,114 additional shares of common stock issuable under its Non-Employee Director Stock Plan, as amended.
Mitesco, Inc. filed a Form 8-K on November 6, 2026, reporting a November 5, 2026 shareholder-approved amendment to increase authorized common shares, unregistered issuances of Series X Preferred Stock to three directors and one existing holder, and ongoing acquisition discussions.
Repligen Corporation filed a Form 8-K on November 6, 2026, disclosing the issuance of $1.0 billion aggregate principal amount of 0.25% Convertible Senior Notes due 2031 through a combination of exchange and cash subscription transactions completed on that same date.
First Busey Corporation filed a Form 8-K on November 6, 2026, disclosing a quarterly cash dividend declared on its 8.25% Fixed-Rate Series B Non-Cumulative Perpetual Preferred Stock.
Karbon-X Corp. filed a Form 8-K on November 6, 2026, disclosing the termination of Chief Financial Officer Adriana Ebell on October 30, 2026, and the appointment of Samuel Hamilton Nelson as CFO effective November 1, 2026.
Medalist Diversified, Inc. (NASDAQ:MDRR) filed an amended current report on November 6, 2026, supplementing its September 18, 2026 original filing to provide financial statements and unaudited pro forma information related to its acquisition of the Pilot Point Property in Texas.
Power Solutions International, Inc. filed a current report on November 6, 2026, disclosing that Chief Financial Officer Xun (Ken) Li notified the board of his resignation effective November 27, 2026.
Nkarta, Inc. filed a current report on Form 8-K on November 6, 2026, disclosing that the company will host a webcast on November 9, 2026, to review initial clinical data from its Ntrust clinical program evaluating NKX019 in myositis and systemic sclerosis.
Latch, Inc. filed a Form 8-K on November 6, 2026, disclosing the immediate resignation of director Andrew Sugrue from the company's Board of Directors and all committees on which he served.
Please wait processing your request...